New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and ...

A joint committee of eleven major U.S. medical organizations has released a new guideline on managing dyslipidemia that ...

Highlights from dyslipidemia research presented at the American College of Cardiology Scientific Sessions 2026, focusing on ...

News from ACC 2026 dominates our most-read list, along with the dyslipidemia guidelines, Lp(a) vs CAC, and apixaban for VTE.

Dyslipidemia is when the lipids in your blood are too high or too low. Estimates suggest that 53 percent of adults in the U.S. have lipid abnormalities. Lipids are a type of fat that make up the ...

Dyslipidemia is when the lipids in your blood are too high or too low. Estimates suggest that 53 percent of adults in the U.S. have lipid abnormalities. Lipids are a type of fat that make up the ...

The chronic high cholesterol market is set to hit $15.53 billion in 2032 across seven major markets, but the need for new drugs and controlled pricing will cause a major shake-up, according to a new ...

Just two-thirds of US adults with severe dyslipidemia are taking a statin medication to lower LDL cholesterol levels, and for younger individuals, specifically those in their 30s and 40s with severe ...

Dyslipidemia spans a spectrum of lipid imbalances, from hyperlipidemia, indicating high lipid levels, to hypolipidemia, reflecting low lipid levels. A thorough understanding of dyslipidemia's causes, ...

Please provide your email address to receive an email when new articles are posted on . The virtual National Lipid Association Scientific Session, held Dec. 10 to 12, covered topics such as ...